Related references
Note: Only part of the references are listed.CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals
Harry B. Gristick et al.
SCIENCE IMMUNOLOGY (2023)
Antiviral neutralizing antibodies: from in vitro to in vivo activity
Dennis R. Burton
NATURE REVIEWS IMMUNOLOGY (2023)
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Prolonged viral suppression with anti-HIV-1 antibody therapy
Christian Gaebler et al.
NATURE (2022)
Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
Colin LaMont et al.
ELIFE (2022)
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth
Xuejun Chen et al.
IMMUNITY (2021)
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
Anna Schorcht et al.
JOURNAL OF VIROLOGY (2021)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang et al.
NATURE MEDICINE (2021)
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
Amelia Escolano et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
Philip J. M. Brouwer et al.
NPJ VACCINES (2021)
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Ronald Derking et al.
CELL REPORTS (2021)
Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography
Young Do Kwon et al.
ANTIBODIES (2021)
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
Philipp Schommers et al.
CELL (2020)
Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin
Rajesh P. Ringe et al.
JOURNAL OF VIROLOGY (2020)
Autologous neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened in rabbits
Yuhe R. Yang et al.
JOURNAL OF VIROLOGY (2020)
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
P. J. Klasse et al.
CELL HOST & MICROBE (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8
Miklos Guttman et al.
SCIENTIFIC REPORTS (2020)
Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
Sonu Kumar et al.
NATURE COMMUNICATIONS (2019)
Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities
Dung N. Nguyen et al.
ACS CENTRAL SCIENCE (2019)
Protein and Glycan Mimicry in HIV Vaccine Design
Gemma E. Seabright et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu et al.
CELL HOST & MICROBE (2019)
Multiple roles for HIV broadly neutralizing antibodies
Barton F. Haynes et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Philip J. M. Brouwer et al.
NATURE COMMUNICATIONS (2019)
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes
Rajesh P. Ringe et al.
JOURNAL OF VIROLOGY (2019)
Harnessing post-translational modifications for next-generation HIV immunogens
Joel D. Allen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
A non-equilibrium approach to allosteric communication
Gerhard Stock et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
P. J. Klasse et al.
PLOS PATHOGENS (2018)
DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions
Beth M. Stadtmueller et al.
IMMUNITY (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
Liwei Cao et al.
NATURE COMMUNICATIONS (2018)
Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
Haoqing Wang et al.
CELL HOST & MICROBE (2018)
Progress toward active or passive HIV-1 vaccination
Amelia Escolano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Marit J. van Gils et al.
NATURE MICROBIOLOGY (2017)
Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1
Anna-Janina Behrens et al.
EXPERT REVIEW OF PROTEOMICS (2017)
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
Jeong Hyun Lee et al.
IMMUNITY (2017)
The HIV-1 envelope glycoprotein structure: nailing down a moving target
Andrew B. Ward et al.
IMMUNOLOGICAL REVIEWS (2017)
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike
Gabriel Ozorowski et al.
NATURE (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise
Dennis R. Burton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein
Liwei Cao et al.
NATURE COMMUNICATIONS (2017)
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
Oliver F. Brandenberg et al.
PLOS PATHOGENS (2017)
Structural principles controlling HIV envelope glycosylation
Anna-Janina Behrens et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins
Eden P. Go et al.
JOURNAL OF VIROLOGY (2016)
PROTEIN PHYSICS Forever ageing
Ralf Metzler
NATURE PHYSICS (2016)
The dynamics of single protein molecules is non-equilibrium and self-similar over thirteen decades in time
Xiaohu Hu et al.
NATURE PHYSICS (2016)
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
Jeong Hyun Lee et al.
SCIENCE (2016)
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Rui Kong et al.
SCIENCE (2016)
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
Anna-Janina Behrens et al.
CELL REPORTS (2016)
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
P. J. Klasse et al.
PLOS PATHOGENS (2016)
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Steven W. de Taeye et al.
CELL (2015)
Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance
Laura K. Pritchard et al.
JOURNAL OF VIROLOGY (2015)
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
Pavel Pugach et al.
JOURNAL OF VIROLOGY (2015)
Insights into the trimeric HIV-1 envelope glycoprotein structure
Andrew B. Ward et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
Jeong Hyun Lee et al.
NATURE COMMUNICATIONS (2015)
Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env
Miklos Guttman et al.
NATURE COMMUNICATIONS (2015)
Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers
Laura K. Pritchard et al.
CELL REPORTS (2015)
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
Ronald Derking et al.
PLOS PATHOGENS (2015)
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
Laura E. McCoy et al.
PLOS PATHOGENS (2015)
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Anthony P. West et al.
CELL (2014)
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Emilia Falkowska et al.
IMMUNITY (2014)
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
Claudia Blattner et al.
IMMUNITY (2014)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Glycosylation and Disulfide Bond Analysis of Transiently and Stably Expressed Clade C HIV-1 gp140 Trimers in 293T Cells Identifies Disulfide Heterogeneity Present in Both Proteins and Differences in O-Linked Glycosylation
Eden P. Go et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Jinghe Huang et al.
NATURE (2014)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera et al.
NATURE (2014)
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity
Raffaello Cimbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
Anila Yasmeen et al.
RETROVIROLOGY (2014)
Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization
Arthur S. Kim et al.
PLOS PATHOGENS (2014)
Minute Time Scale Prolyl Isomerization Governs Antibody Recognition of an Intrinsically Disordered Immunodominant Epitope
Marisol Fassolari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Neutralizing IgG at the Portal of Infection Mediates Protection against Vaginal Simian/Human Immunodeficiency Virus Challenge
Katja Klein et al.
JOURNAL OF VIROLOGY (2013)
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
Rajesh P. Ringe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Dmitry Lyumkis et al.
SCIENCE (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Peter D. Kwong et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors
Thomas J. Ketas et al.
VIROLOGY (2012)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Direct observation of disulfide isomerization in a single protein
Jorge Alegre-Cebollada et al.
NATURE CHEMISTRY (2011)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
Katie J. Doores et al.
JOURNAL OF VIROLOGY (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Few and Far Between: How HIV May Be Evading Antibody Avidity
Joshua S. Klein et al.
PLOS PATHOGENS (2010)
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
Brandon F. Keele et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
Joshua S. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genetic and antigenic features of the transmitted virus
Brandon F. Keele et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody
Per Johan Klasse
VIROLOGY (2007)
Prolyl cis-trans isomerization as a molecular timer
Kun Ping Lu et al.
NATURE CHEMICAL BIOLOGY (2007)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant
XL Wu et al.
JOURNAL OF VIROLOGY (2006)
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
P Poignard et al.
JOURNAL OF VIROLOGY (2003)
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber et al.
BRITISH MEDICAL BULLETIN (2001)
Share Paper
